Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy
Completed · Phase 2
Conditions studied: Prostate Cancer
In brief
The study will have two treatment groups, evaluating two Degarelix doses. First dose is the initial dose followed by a maintenance dose given every three months. The initial dose given to suppress the testosterone level and the three month maintenance dose to maintain the suppressed testosterone level over one year of treatment.
Key facts
- Study ID
- NCT00468286
- Run by
- Ferring Pharmaceuticals
- People needed
- 133
- Starts
- 2007-05-01
- Expected to finish
- 2008-08-01
- Last updated by the study team
- 2011-03-23
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Urology Centers of Alabama — Homewood, Alabama, United States
- South Orange County Medical Research Center — Laguna Woods, California, United States
- South Florida Medical Research — Aventura, Florida, United States
- Florida Foundation for Healthcare Research — Ocala, Florida, United States
- Regional Urology — Shreveport, Louisiana, United States
- Investigational site — Carmel, New York, United States
- The Urology Center — Greensboro, North Carolina, United States
- State College Urologic Association — State College, Pennsylvania, United States
- Grand Strand Urology — Myrtle Beach, South Carolina, United States
- Urology of Virginia Research — Norfolk, Virginia, United States
- Urology Research Center — Seattle, Washington, United States
- Investigational site — Surrey, British Columbia, Canada
- Investigational site — Victoria, British Columbia, Canada
- Investigational site — Kentville, Nova Scotia, Canada
- The Female/Male Health Centres — Ontario, Canada
- Nemocnice Jindrichuv Hradec a.s. — Hradec, Czechia
- Slezska nemocnice — Opava, Czechia
- Vseobecna fakultni nemocnice v Praze — Prague, Czechia
- Dombóvári Szent Lukács Egészségügyi Kht — Dombóvár, Hungary
- Borsod-Abaúj-Zemplé n Megyei Kórház és Egyetemi Oktató Kórház — Miskolc, Hungary
- Miskolc Megyei Jogú Város Önkormányzat Miskolci Egészségügyi Központ — Miskolc, Hungary
- Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ — Szeged, Hungary
- Private Medical Center — Arad, Romania
- "Prof Dr Th Burghele" Clinical Hospital — Bucharest, Romania
- Dinu Uromedica — Bucharest, Romania
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.